Cynthia N Chauvin-Fleurence

4PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 20, 2025
A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function.

Daniel Landi, Shoba A Navai, Rebecca M Brock

|Dec 09, 2022
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells.

Ho Ngai, Gabriel A Barragan, Gengwen Tian

|Oct 13, 2020
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis.

Andras Heczey, Amy N Courtney, Antonino Montalbano

|Sep 12, 2019
NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells.

Cynthia Chauvin, Noémie Joalland, Jeanne Perroteau

Pageof 1